Therapeutic methods for burning mouth syndrome: an umbrella review
Background: An umbrella review on the treatment of burning mouth syndrome (BMS) may aid clinicians in selecting the most effective treatment modality to improve patients’ symptoms based on the best available evidence.
Aim: The aim of the study was to perform an umbrella review of available systematic reviews on therapeutic methods used to alleviate BMS symptoms.
Methods: This study was conducted following the Preferred Reporting for Systematic Reviews and Meta-analyses and is registered with the Prospective Register of Systematic Reviews (registration number CRD42021268587). The following databases were searched: PubMed, the Cochrane Library, Scopus, Embase, and Web of Science. The PICOT question was “For the relief of symptomatology, discomfort, and burning sensation caused by BMS, what is the best strategy?” A total of 197 articles were retrieved. After eliminating duplicates, 101 studies were evaluated for inclusion. Finally, eight articles were included in the study.
Results: The most indicated pharmacological measure was clonazepam with short- and long-term effects on symptomatology relief. However, a standardized BMS treatment protocol is not described in the literature, since non-pharmacological therapeutic measures, such as psychotherapy and placebos, reduce the symptomatology of the pathology. The quality of the studies was analyzed through the evaluation of systematic reviews in dentistry (Glenny scale) and the Assessment of the Methodological Quality of Systematic Reviews (AMSTAR 2). According to the Glenny scale, the included studies are of moderate-to-high quality. However, according to AMSTAR 2, only two studies are of a high-quality level, while the others are classified as critically low.
Conclusion: The use of pharmacological (clonazepam) and non-pharmacological (psychotherapy and placebo) measures reduces BMS symptoms.
Relevance for Patients: This review on BMS treatment may aid clinicians in making better-informed decisions regarding treatment modality based on the best available evidence.
[1] Khawaja SN, Alaswaiti OF, Scrivani SJ. Burning Mouth Syndrome. Dent Clin North Am 2023;67:49-60. doi: 10.1016/j.cden.2022.07.004
[2] Alvarenga-Brant R, Costa FO, Mattos-Pereira G, Esteves-Lima RP, Belém FV, Lai H, et al. Treatments for Burning Mouth Syndrome: A Network Meta-analysis. J Dent Res 2023;102:135-45. doi: 10.1177/00220345221130025
[3] Headache Classification Committee of the International Headache Society (IHS) the International Classification of Headache Disorders, 3rd Edition. Cephalalgia 2018;38:1-211. doi: 10.1177/0333102417738202
[4] International Classification of Orofacial Pain, 1st Edition (ICOP). Cephalalgia 2020;40:129-221. doi: 10.1177/0333102419893823
[5] Reyad AA, Mishriky R, Girgis E. Pharmacological and Non-pharmacological Management of Burning Mouth Syndrome: A Systematic Review. Dent Med Probl 2020;57:295-304. doi: 10.17219/dmp/120991
[6] Adamo D, Spagnuolo G. Burning Mouth Syndrome: An Overview and Future Perspectives. Int J Environ Res Public Health 2022;20:682. doi: 10.3390/ijerph20010682
[7] Thakkar J, Dym H. Management of Burning Mouth Syndrome. Dent Clin North Am 2024;68:113-9. doi: 10.1016/j.cden.2023.07.007
[8] Russo M, Crafa P, Guglielmetti S, Franzoni L, Fiore W, Di Mario F. Burning Mouth Syndrome Etiology: ANarrative Review. J Gastrointestin Liver Dis 2022;31:223-8. doi: 10.15403/jgld-4245
[9] Ślebioda Z, Lukaszewska-Kuska M, DorockaBobkowska B. Evaluation of the Efficacy of Treatment Modalities in Burning Mouth Syndrome-a Systematic Review. J Oral Rehabil 2020;47:1435-7. doi: 10.1111/joor.13102
[10] Porporatti AL, Schroder ÂG, Lebel A, Moreau N, Misery L, Alajbeg I, et al. Is Burning Mouth Syndrome Associated with Stress? A Meta-analysis. J Oral Rehabil 2023;50:1279-315. doi: 10.1111/joor.13536
[11] Nosratzehi T. Burning Mouth Syndrome: A Review of Therapeutic Approach. J Complement Integr Med 2021;19:83-90. doi: 10.1515/jcim-2021-0434
[12] Thakkar JP, Lane CJ. Hyposalivation and Xerostomia and Burning Mouth Syndrome: Medical Management. Oral Maxillofac Surg Clin North Am 2022;34:135-46. doi: 10.1016/j.coms.2021.08.002
[13] Kisely S, Baghaie H, Lalloo R, Johnson NW. Association between Poor Oral Health and Eating Disorders: Systematic Review and Meta-analysis. Br J Psychiatry 2015;207:299-305. doi: 10.1192/bjp.bp.114.156323
[14] Shin HI, Bang JI, Kim GJ, Kim MR, Sun DI, Kim SY. Therapeutic Effects of Clonazepam in Patients with Burning Mouth Syndrome and Various Symptoms or Psychological Conditions. Sci Rep 2023;13:7257. doi: 10.1038/s41598-023-33983-6
[15] Souza IF, Mármora BC, Rados PV, Visioli F. Treatment Modalities for Burning Mouth Syndrome: A Systematic Review. Clin Oral Investig 2018;22:1893-905. doi: 10.1007/s00784-018-2454-6
[16] Liu YF, Kim Y, Yoo T, Han P, Inman JC. Burning Mouth Syndrome: A Systematic Review of Treatments. Oral Dis 2018;24:325-34. doi: 10.1111/odi.12660
[17] McMillan R, Forssell H, Buchanan JA, Glenny AM, Weldon JC, Zakrzewska JM. Interventions for Treating Burning Mouth Syndrome. Cochrane Database Syst Rev 2016;11:CD002779. doi: 10.1002/14651858
[18] Kisely S, Forbes M, Sawyer E, Black E, Lalloo R. A Systematic Review of Randomized Trials for the Treatment of Burning Mouth Syndrome. J Psychosom Res 2016;86:39-46. doi: 10.1016/j.jpsychores.2016.05.001
[19] Kuten-Shorrer M, Kelley JM, Sonis ST, Treister NS. Placebo Effect in Burning Mouth Syndrome: A Systematic Review. Oral Dis 2014;20:e1-6. doi: 10.1111/odi.12192
[20] Tan HL, Smith JG, Hoffmann J, Renton T. A Systematic Review of Treatment for Patients with Burning Mouth Syndrome. Cephalalgia 2022;42:128-61. doi: 10.1177/03331024211036152
[21] Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: The PRISMA Statement. Int J Surg 2010;8:336-41. doi: 10.1016/j.ijsu.2010.02.007
[22] Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: A Critical Appraisal Tool for Systematic Reviews that Include Randomised or Non-Randomised Studies of Healthcare Interventions, or Both. BMJ 2017;358:j4008. doi: 10.1136/bmj.j4008
[23] Glenny AM, Esposito M, Coulthard P, Worthington HV. The Assessment of Systematic Reviews in Dentistry. Eur J Oral Sci 2003;111:85-92. doi: 10.1034/j.1600-0722.2003.00013.x
[24] Brozek JL, Akl EA, Alonso-Coello P, Lang D, Jaeschke R, Williams JW, et al. Grading Quality of Evidence and Strength of Recommendations in Clinical Practice Guidelines. Part 1 of 3. An Overview of the GRADE Approach and Grading Quality of Evidence about Interventions. Allergy 2009;64:669-77. doi: 10.1111/j.1398-9995.2009.01973.x
[25] Griffin CE 3rd, Kaye AM, Bueno FR, Kaye AD. Benzodiazepine Pharmacology and Central Nervous System-Mediated Effects. Ochsner J 2013;13:214-23.
[26] Bartoshuk LM, Snyder DJ, Grushka M, Berger AM, Duffy VB, Kveton JF. Taste Damage: Previously Unsuspected Consequences. Chem Senses 2005;30: i218-9. doi: 10.1093/chemse/bjh192
[27] Rodríguez de Rivera Campillo E, López-López J, Chimenos-Küstner E. Response to Topical Clonazepam in Patients with Burning Mouth Syndrome: A Clinical Study. Bull Group Int Rech Sci Stomatol Odontol 2010;49:19-29.
[28] Souto-Maior JR, Pellizzer EP, De Luna Gomes JM, Dds CA, Dds JF, Vasconcelos BC, et al. Influence of Diabetes on the Survival Rate and Marginal Bone Loss of Dental Implants: An Overview of Systematic Reviews. J Oral Implantol 2019;45:334-40.
[29] Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-analyses: The PRISMA Statement. PLoS Med 2009;6:e1000097. doi: 10.1371/journal.pmed.1000097
[30] Ford AC, Wright-Hughes A, Alderson SL, Ow PL, Ridd MJ, Foy R, et al. Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in primary care (ATLANTIS): A Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial. Lancet 2023;402:1773-85. doi: 10.1016/S0140-6736(23)01523-4